SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : MDA - Market Direction Analysis -- Ignore unavailable to you. Want to Upgrade?


To: Haim R. Branisteanu who wrote (42691)3/9/2000 11:55:00 PM
From: pater tenebrarum  Read Replies (1) | Respond to of 99985
 
Haim, you can calculate it:

this is the formula: cash [1+r (x/365)] - dividends

whereby r is the risk-free interest rate (currently 5,66% p.a.) and x the remaining lifetime of the contract in days. i guess the dividends are negligible in this case...

regards,

hb



To: Haim R. Branisteanu who wrote (42691)3/10/2000 1:05:00 PM
From: flatsville  Read Replies (2) | Respond to of 99985
 
OT--haim,

re: our prior scln discussion-

A synopsis of today's IBD's New American article on scln--

>>>Headline 'BIOTECH GOES OVERSEAS TO MARKET TREATMENT FOR HEPATITIS PATIENTS'
There is a story about a DR. James Kim who came down with HEP in '83. Treated with INTRON and had lot of side effects. In 1992 He heard of Zadaxin, flew to ITALY for treatment. "The drug saved my life! It was my last resort." His life is now back to normal. He jogs and plays tennis.
He sold his whole portfolio and put into SCLN. It is now worth $4.3 million.
Zadaxin works alone but works better with other drugs. It talks about the 16 other countries.
It interviews Sellers and he gives ALL th good data. There is a comment from RED CHIP REVIEW> It then talks about the financials.<<<


The stock is still a little beat-up from a drop from $22 3/4 to 16 earlier this week. It will be out of the teens by next week for certain...Assuming it is not the end of the Naz as we know it, yet again. <ggg>